XPC and ovarian cancer: Herein we demonstrated that an orphan receptor tyrosine kinase TIE-1 up-regulates XPC-dependent NER rendering ovarian cancer cells resistant to platinum reagents and is a key determinant responsible for the therapeutic efficacy of DNA-damaging reagents in ovarian cancer by controlling a DNA repair system.